DONGGUAN, China — Fapon Biotech Inc. (The Company or “Fapon Biotech”) is pleased to announce its full acquisition of Sequlite Genomics (“Sequlite”), a USA enterprise that focuses on Next-Generation Sequencing (“NGS”). The two parties have signed a share purchase agreement online, with the Fapon Biotech team in Dongguan headquarter and Sequlite team in the USA. […]
Life science research distributor Nordic BioSite Group acquires Austrian Szabo Scandic to further expand geographical footprint – with ultimate goal of becoming an even stronger partner to its suppliers and customers. Nordic BioSite Group (NBG) is a leading European supplier of research and diagnostics products, with a particularly strong position within antibodies and other research […]
Leaders in tech, biotech, and synthetic biology join to advance first commercial molecular electronics chip SAN DIEGO, Calif. — Roswell Biotechnologies, Inc., the molecular electronics company, announced today the formation of its Scientific Advisory Board (SAB). Comprised of industry and academic leaders in science and technology, the new SAB will be instrumental in the final […]
Whole-genome sequencing (WGS) enables faster identification of disease-causing genetic abnormalities in infants improving clinical care and management SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced an agreement with Israel’s Ministry of Health (MoH) for a pilot program to implement the use of whole-genome sequencing (WGS) in critically-ill infants suspected of having a genetic disorder […]
New Funding, Targeted to Accelerate Application Expansion and Platform Commercialization, Brings Total Amount Raised to Date to $280M SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C financing led by Coatue Management […]
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain meaningful genomic […]
Strengthens supply chain continuity with first manufacturing facility outside of the U.S. SINGAPORE — 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today marked a major Asia Pacific (APAC) expansion with the grand opening celebration of its Singapore manufacturing facility and commercial hub. The addition of the […]
ARIA improves the precision, breadth and rate of discovery of meaningful connections between genetics and health outcomes at the 1M+ participant scale BOSTON — Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced that ARIA™, the company’s powerful cloud-based solution to help researchers integrate and analyze complex sets of genomic data at the population level, is now […]
Veteran Life Science Executives Bring Deep Expertise to Advance the Company’s Enzymatic DNA Synthesis (EDS) Technology and Commercialize its SYNTAX Platform SOUTH SAN FRANCISCO, Calif., and PARIS DNA Script, a leader in Enzymatic DNA Synthesis (EDS), today announced the appointment of Don Kania, Ph.D. as Chairman of the Board of Directors, Catherine Moukheibir as Audit […]
ATDBio, a leader in complex oligonucleotide synthesis, is pleased to announce that it has been acquired by the Swedish life sciences company Biotage AB for approximately GBP 45m in cash and shares. The acquisition, which provides Biotage with expertise in highly complex DNA and RNA production, will allow accelerated expansion of the UK company’s activities. ATDBio’s founders […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
